These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28592124)

  • 1. Long non-coding RNA MALAT1 promotes cholangiocarcinoma cell proliferation and invasion by activating PI3K/Akt pathway.
    Wang C; Mao ZP; Wang L; Wu GH; Zhang FH; Wang DY; Shi JL
    Neoplasma; 2017; 64(5):725-731. PubMed ID: 28592124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
    Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
    Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
    Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression.
    Liang Z; Ge Y; Li J; Bai Y; Xiao Z; Yan R; An G; Zhang D
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):342. PubMed ID: 38980538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
    Gu Y; Zhu Z; Pei H; Xu D; Jiang Y; Zhang L; Xiao L
    Aging (Albany NY); 2020 Feb; 12(3):2333-2346. PubMed ID: 32019904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
    Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
    Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling.
    Wei CX; Wong H; Xu F; Liu Z; Ran L; Jiang RD
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8169-8178. PubMed ID: 30556855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MALAT1 affects high glucose-induced endothelial cell proliferation, apoptosis, migration and angiogenesis by regulating the PI3K/Akt signaling pathway.
    Zhang SH; Zhang SG; Zhou P; Wei X; Mao XD; Lin SG; Liu C
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8551-8559. PubMed ID: 31646587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.
    Zhu B; Wei Y
    Cancer Med; 2020 Jan; 9(2):783-796. PubMed ID: 31957323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
    Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway.
    Chen Y; Huang W; Sun W; Zheng B; Wang C; Luo Z; Wang J; Yan W
    Cell Physiol Biochem; 2018; 51(3):1313-1326. PubMed ID: 30481748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long noncoding RNA MALAT1/microRNA-598-3p axis regulates the proliferation and apoptosis of retinoblastoma cells through the PI3K/AKT pathway.
    Lin X; Huang X; Wang L; Liu W
    Mol Vis; 2022; 28():269-279. PubMed ID: 36284668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MALAT1 regulates trophoblast cells migration and invasion via miR-206/IGF-1 axis.
    Wu HY; Wang XH; Liu K; Zhang JL
    Cell Cycle; 2020 Jan; 19(1):39-52. PubMed ID: 31774373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MALAT1 Expression Regulates Breast Cancer Progression via PI3K/AKT/mTOR Pathway Modulation.
    Naveed M; Malik A; Anjum H; Ijaz B
    Biochem Genet; 2024 Oct; 62(5):3421-3438. PubMed ID: 38110774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT.
    Zhang Y; Ji G; Han S; Shao Z; Lu Z; Huo L; Zhang J; Yang R; Feng Q; Shen H; Wang H; Li X
    Cell Physiol Biochem; 2018; 50(2):612-628. PubMed ID: 30308494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway.
    Wang N; Hou MS; Zhan Y; Shen XB; Xue HY
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7653-7659. PubMed ID: 30536307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quercetin promotes the apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis by upregulating lncRNA MALAT1.
    Pan F; Zhu L; Lv H; Pei C
    Int J Mol Med; 2016 Nov; 38(5):1507-1514. PubMed ID: 28026003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.